| |
|
|
|
Xtalks, online
2023 -5-24
Series Description
The value of real-world data is clear. The acceptance of real-world evidence (RWE) is growing. But is this enough to propel RWE from being a nice-to-have to a must-have? PicnicHealth is hosting a four-part webinar series to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction?
Webinar Description
With increasing applications of real-world data (RWD) upstream in the drug development lifecycle, it’s critical to recognize that there is no one-size-fits-all approach. So how can one incorporate different types of data from patients into clinical trials? Through conversation with a panel of experts from the biopharma industry and health technology companies, the featured speakers will discuss scenarios when patient-mediated, tokenized and/or site-based approaches are warranted. Speakers will share their unique perspectives on the importance of a tailored yet flexible strategy and the potential value this can unlock for researchers and patients alike.
Join today to explore design considerations for incorporating different types of real-world data into clinical trials.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Gaelan Ritter, Head of Analytics Innovation and Digital Health, Bristol-Myers Squibb Andrew Larsen, VP of Partnerships, PicnicHealth Jim Coutcher, Senior Director, Global Head of Emerging Methods and Solutions, Real World Solutions, IQVIA (Moderator) Evelyn Pyper, Evidence Strategist, PicnicHealth
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -5-24
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|